137 related articles for article (PubMed ID: 38176331)
1. The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade.
Li S; Tang T; Han J; Liu W; Chen R; Deng H; Jian T; Fu Z
Cancer Epidemiol; 2024 Feb; 88():102515. PubMed ID: 38176331
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
3. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.
Nieto A; Ruiz-Ramos M; Abdel-Kader L; Conde M; Camacho F
Br J Dermatol; 2003 Jan; 148(1):110-6. PubMed ID: 12534603
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Prognostic Factors for Merkel Cell Carcinoma, Mucosal Melanoma and Cutaneous Malignant Melanoma: Insights into Their Etiologies.
Dennis LK; Brown HE; Arrington AK
Curr Oncol; 2023 Mar; 30(4):3974-3988. PubMed ID: 37185414
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous malignant melanoma--clinical epidemiology and survival.
Nair MK; Varghese C; Mahadevan S; Cherian T; Joseph F
J Indian Med Assoc; 1998 Jan; 96(1):19-20, 28. PubMed ID: 9601186
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
Buja A; Rugge M; De Luca G; Bovo E; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Spina R; Cinquetti S; Baldo V; Rossi CR; Mocellin S
Curr Oncol; 2022 Mar; 29(3):2165-2173. PubMed ID: 35323375
[TBL] [Abstract][Full Text] [Related]
9. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.
Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M
Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355
[TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
13. Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy.
Bucchi L; Mancini S; Crocetti E; Dal Maso L; Baldacchini F; Vattiato R; Giuliani O; Ravaioli A; Caldarella A; Carrozzi G; Ferretti S; Filiberti RA; Fusco M; Gatti L; Gili A; Magoni M; Mangone L; Mazzoleni G; Michiara M; Panato C; Piffer S; Piras D; Rosso S; Rugge M; Scala U; Tagliabue G; Tumino R; Stanganelli I; Falcini F
Int J Cancer; 2021 Feb; 148(4):835-844. PubMed ID: 33405292
[TBL] [Abstract][Full Text] [Related]
14. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
Huang K; Fan J; Misra S
J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
[TBL] [Abstract][Full Text] [Related]
15. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous malignant melanoma.
Cummins DL; Cummins JM; Pantle H; Silverman MA; Leonard AL; Chanmugam A
Mayo Clin Proc; 2006 Apr; 81(4):500-7. PubMed ID: 16610570
[TBL] [Abstract][Full Text] [Related]
18. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Survival, and Mortality of Malignant Cutaneous Melanoma in Wisconsin, 1995-2011.
Peterson M; Albertini MR; Remington P
WMJ; 2015 Oct; 114(5):196-201. PubMed ID: 26726340
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous melanoma in older patients.
Buja A; Rugge M; Trevisiol C; Zanovello A; Brazzale AR; Zorzi M; Vecchiato A; Del Fiore P; Tropea S; Rastrelli M; Rossi CR; Mocellin S
BMC Geriatr; 2024 Mar; 24(1):232. PubMed ID: 38448833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
